Research presented at the American Academy of Dermatology Annual Meeting 2024 explored the impact of social determinants of health on hidradenitis suppurativa severity.
This content was produced independently by The American Journal of Managed Care® and is not endorsed by the American Academy of Dermatology.
Research presented at the American Academy of Dermatology Annual Meeting 2024 explored the impact of social determinants of health (SDOH) on hidradenitis suppurativa (HS) severity. The findings indicate a link between socioeconomic factors and progression of the debilitating skin condition. The poster presentation elaborated on the significant role that social vulnerability plays in determining the severity of HS, highlighting the need for targeted interventions to address these disparities and improve outcomes for affected individuals.
Because there’s been limited research on this relationship, the investigation, led by researchers in the southeastern US, delved into the correlation between various SDOH factors and the severity of HS using geocoding and census tract–level data.
The study was conducted at a single institution's Dermatology department and involved 1384 patients with HS whose home addresses were geocoded and linked to census tracts. These tracts were then assessed using the Social Vulnerability Index, a tool developed by the CDC to evaluate neighborhood-level social needs. The researchers explored several other measures of SDOH, including access to urgent care and hospitals, unemployment rates, vehicle and internet access, median household income, and poverty levels. The analysis was adjusted for sex, race, body mass index, smoking status, and age of onset.
Results reveal that among the patients studied, 64% (n = 886) had mild to moderate HS (Hurley stage I/II), while 36% (n = 498) exhibited severe HS (Hurley stage III). The data indicated a significant association between higher social vulnerability and the severity of HS, with Hurley stage III disease being over twice as likely to occur in socially vulnerable areas compared with milder stages (OR, 2.07; 95% CI, 1.33-3.22; P = .001).
Additionally, modest associations were found between severe HS and tract-level unemployment rates (OR, 1.03; 95% CI, 1.00-1.06; P = .028), lack of access to vehicles (OR, 1.03; 95% CI, 1.01-1.05; P = .004), and limited internet access (OR, 1.03; 95% CI, 1.02-1.04; P < .001). However, no significant correlations were found between urgent care and hospital access, household income, and HS severity.
Although the findings of this study underscore the significant impact of overall social vulnerability on the severity of HS, the researchers acknowledged some limitations to their analysis. Census tract–level data for SDOH may not apply to the specific patient, and because the patient population was largely from North Carolina, the findings may not be generalizable.
They noted that further research is warranted to validate these trends at a national level, potentially paving the way for more targeted interventions and support systems to mitigate the effects of SDOH on patients with HS. Understanding these associations could lead to improved management strategies and better outcomes for affected individuals.
Reference
Shams R, McDaniel P, Stitzenberg K, Sayed C. Social determinants of health and hidradenitis suppurative disease severity: a geocoded and census tract level analysis. Poster presented at: American Academy of Dermatology Annual Meeting 2024; March 8, 2024; San Diego, CA. Poster 49636
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
2 Commerce Drive
Cranbury, NJ 08512